WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Earnings & Revenue

Open Broker Account

AMGN past earnings growth

How has AMGN's earnings growth performed historically?
Company
19.49%
Industry
53.02%
Market
53.18%
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMGN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMGN past revenue growth

How has AMGN's revenue growth performed historically?
Company
3.53%
Industry
19.06%
Market
113.02%
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMGN earnings and revenue history

Current Revenue
$26.4B
Current Earnings
$6.6B
Current Profit Margin
24.9%
AMGN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

AMGN Return on Equity

Current Company
144.1%
Current Industry
41.5%
Current Market
25.7%
AMGN's Return on Equity (144.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMGN announces earnings.

AMGN Return on Assets

Current Company
10.8%
Current Industry
10.3%
AMGN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMGN Return on Capital Employed

Current Company
18.74%
Current Industry
15.9%
AMGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMGN vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMGN$26.38B$12.12B$6.58B+2.74%+1.36%
SNY$42.46B$11.96B$6.71B+1.30%-7.60%
BMY$47.14B$18.11B$6.62B+18.43%+1.88%
GILD$27.52B$8.65B$4.14B-0.68%-18.72%
NVS$52.79B$21.56B$22.98B+1.41%+30.20%

AMGN earnings dates

Next earnings date
Oct 31, 2022

Amgen Earnings & Revenue FAQ

What were AMGN's earnings last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q2 2022 earnings per share (EPS) of $2.46, up 203.7% year over year. Total Amgen earnings for the quarter were $1.32 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $0.81.

If you're new to stock investing, here's how to buy Amgen stock.

What was AMGN's earnings growth in the past year?

As of Q4 2022, Amgen's earnings has grown 19.49% year over year. This is 33.52 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 53.02%. Amgen's earnings in the past year totalled $6.58 billion.

What is AMGN's earnings date?

Amgen's earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.

What was AMGN's revenue last quarter?

On Invalid Date, Amgen (NASDAQ: AMGN) reported Q2 2022 revenue of $6.59 billion up 1.04% year over year. In the same quarter last year, Amgen's revenue was $6.53 billion.

What was AMGN's revenue growth in the past year?

As of Q4 2022, Amgen's revenue has grown 3.53% year over year. This is 15.53 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 19.06%. Amgen's revenue in the past year totalled $26.38 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.